do not combine dpp-4 inhibitor with glp-1 receptor agonist guideline inhibitors agonists guidance SGLT-2 inhibitors, GLP GLP 1 Receptor Agonists and
Description
Overcoming barriers such as availability, affordability and clinical awareness could broaden implementation in clinical practice

2025 Jul 28;23(4):337-343

Specifically, Saxenda is indicated for chronic weight management in obese adults (BMI 30) or those merely overweight with a BMI 27 and a weight-related comorbidity such as hypertension, dyslipidemia, or diabetes

While IIH can be a deleterious condition leading to visual worsening or even blindness, it is also associated with reduced quality of life due to severe headache [27]

doi: 10.1016/j.neuroscience.2014.02.022 180 ZhangSXCaiHYMaXWYuanLZhangJWangZJet al
